Xenon Pharmaceuticals Outlines 2019 Key Milestones
Innovative Product Pipeline Includes Multiple Neurology-Focused Products Anticipated to be in Phase 2 or Later Stage Development in 2019 BURNABY, […]
Innovative Product Pipeline Includes Multiple Neurology-Focused Products Anticipated to be in Phase 2 or Later Stage Development in 2019 BURNABY, […]
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance —— Generated Pre-Orders for More Than 30 […]
Advancing Novel Gene Therapy ADVM-022 for Wet AMD in OPTIC Phase 1 Clinical Trial MENLO PARK, Calif., Jan. 06, 2019 […]
Subscribers can signal their monitoring station directly from the Alarm.com mobile app to enable faster emergency response and reduce false […]
TYSONS, Va. and LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) — Alarm.com, the leading platform for the intelligently connected property, […]
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 06, 2019 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a […]
HONG KONG, Jan. 07, 2019 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company […]
Mechelen, Belgium; 6 January 2019, 22.01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) expands its clinical study program with […]
— Built to deliver best mobile computing experiences with unmatched feature sets, powerful compute performance, and battery life to get […]
— GOCOVRI preliminary net sales of approximately $13.3 million for the fourth quarter of 2018 and approximately $34 million for […]